A validated micellar electrokinetic chromatography method for the quantitation of dexamethasone, ondansetron and aprepitant, antiemetic drugs, in organogel

Journal of Pharmaceutical and Biomedical Analysis

Volumn 86, Issue , 2013, Pages 40-48

  Bourdon, Florence ^a   Lecoeur, Marie ^a   Duhaut, Marion ^a   Odou, Pascal ^a   Vaccher, Claude ^a   Foulon, Catherine ^a  

^a Cité scientifique   (France)

Author keywords

Aprepitant; Central composite design; Dexamethasone; Micellar electrokinetic chromatography; Ondansetron

Indexed keywords

APREPITANT; BORIC ACID; DEXAMETHASONE; DODECYL SULFATE SODIUM; ELECTROLYTE; METHANOL; ONDANSETRON; SILICON DIOXIDE;

ACCURACY; ARTICLE; DRUG FORMULATION; DRUG QUALITY; GEL; MEASUREMENT REPEATABILITY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; ORGANOGEL; PH; PRIORITY JOURNAL; SEPARATION TECHNIQUE;

APREPITANT; CCD; CENTRAL COMPOSITE DESIGN; DESIGN OF EXPERIMENTS; DEXAMETHASONE; DOE; MEKC; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; ONDANSETRON;

ANTIEMETICS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; DEXAMETHASONE; GELS; MORPHOLINES; ONDANSETRON;

EID: 84883015668     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.07.029     Document Type: Article

References (27)

1. Basch E., Prestrud A.A., Hesketh P.J., Kris M.G., Feyer P.C., Somerfield M.R., Chesney M., Clark-Snow R.A., Flaherty A.M., Freundlich B., Morrow G., Rao K.V., Schwartz R.N., Lyman G.H. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 2011, 29:4189-4198.
2. Roila F., Herrstedt J., Aapro M., Gralla R.J., Einhorn L.H., Ballatori E., Bria E., Clark-Snow R.A., Espersen B.T., Feyer P., Grunberg S.M., Hesketh P.J., Jordan K., Kris M.G., Maranzano E., Molassiotis A., Morrow G., Olver I., Rapoport B.L., Rittenberg C., Saito M., Tonato M., Warr D. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Annals of Oncology 2010, 21:232-243.
3. Navari R.M. Treatment of chemotherapy-induced nausea. Community Oncology 2012, 9:20-26.
4. Jordan K., Sippel C., Schmoll H.-J., Symptom Management Supportive care guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. The Oncologist 2007, 12:1143-1150.
5. Hesketh P.J., Grunberg S.M., Gralla R.J., Warr D.G., Roila F., de Wit R., Chawla S.P., Carides A.D., Ianus J., Elmer M.E., Evans J.K., Beck K., Reines S., Horgan K.J. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-the aprepitant protocol 052 study group. Journal of Clinical Oncology 2003, 21:4112-4119.
6. Yeo W., Mo F.K.F., Suen J.J.S., Ho W.M., Shan S.L., Lau W., Koh J., Yeung W.K., Kwan W.H., Lee K.K.C. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy. Breast Cancer Research and Treatment 2009, 113:529-535.
7. Smyth W.F. Recent applications of capillary electrophoresis-electrospray ionisation-mass spectrometry in drug analysis. Electrophoresis 2006, 27:2051-2062.
8. Espada A., Molina-Martin M. Capillary electrophoresis and small molecule drug discovery: a perfect match. Drug Discovery Today 2012, 17:396-404.
9. Candioti L.V., Robles J.C., Mantovani V.E., Goicoechae H.C. Multiple response optimization applied to the development of a capillary electrophoretic method for pharmaceutical analysis. Talanta 2006, 69:140-147.
10. Bayens V., Varesio E., Veuthey J.-L., Gurny R. Determination of dexamethasone in tears by capillary electrophoresis. Journal of Chromatography B 1997, 692:222-226.
11. Altria K.D., McLean R. Development and optimisation of a generic micellar electrokinetic capillary chromatography method to support analysis of a wide range of pharmaceuticals and excipients. Journal of Pharmaceutical and Biomedical Analysis 1998, 18:807-813.
12. El Deeb S., Iriban M.A., Gust R. MEKC as a powerful growing analytical technique. Electrophoresis 2011, 32:166-183.
13. Song L., Bai J., Zhou W. Determination of betamethasone and dexamethasone in human urine and serum by MEKC after an experimental design. Chromatographia 2008, 68:287-293.
14. He J., Shamsi S.A. Multivariate approach for the enantioselective analysis in micellar electrokinetic chromatography-mass spectrometry: I. Simultaneous optimization of binaphthyl derivatives in negative ion mode. Journal of Chromatography A 2009, 1216:845-856.
15. Danel C., Chaminade P., Odou P., Bartélémy C., Azarzar D., Bonte J-P., Vaccher C. Enantioselective analysis of the antipsychotic 9-hydroxyrisperidone, main metabolite of risperidone, by chiral capillary EKC using dual CDs. Electrophoresis 2007, 28:2683-2692.
16. Lecoeur M., Goossens J.-F., Vaccher C., Bonte J.-P., Foulon C. A multivariate approach for the determination of isoelectric point of human carbonic anhydrase isoforms by capillary isoelectric focusing. Electrophoresis 2011, 32:2857-2866.
17. Sentellas S., Saurina J. Chemometrics in capillary electrophoresis. Part A: methods for optimization. Journal of Separation Science 2003, 26:875-885.
18. Ph.Hubert, Nguyen-Hu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal - part I. Journal of Pharmaceutical and Biomedical Analysis 2004, 36:579-586.
19. Ph.Hubert, Nguyen-Hu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., Rozet E. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal - Part II. Journal of Pharmaceutical and Biomedical Analysis 2007, 45:70-81.
20. Ph.Hubert, Nguyen-Hu J.J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Laurentie M., Mercier N., Muzard G., Valat L., Rozet E. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal - Part III. Journal of Pharmaceutical and Biomedical Analysis 2007, 45:82-96.
21. Afect Traité de chimie thérapeutique: médicaments actifs sur le sytème nerveux central 2011, Lavoisier, Paris.
22. Tomida H., Yotsuyanagi T., Ikeda K. Solubilization of steroid hormones by polyethylene lauryl ether. Chemical and Pharmaceutical Bulletin 1978, 26:2832-2837.
23. Olver I., Shelukar S., Thompson K.C. Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant. International Journal of Nanomedicine 2007, 2:13-18.
24. Lemus Gallego J.M., Pérez Arroyo J. Simultaneous determination of hydrocortisone, oxytetracycline and nystatin by liquid chromatography. Chromatographia 2002, 56:455-462.
25. Silva M. MEKC, an update focusing on practical aspects. Electrophoresis 2007, 28:174-192.
26. Eriksson L., Johansson E., Kettaneh-Wold N., Wikström C., Wold S. Design of Experiments - Principles and Applications 2008, Umetrics, Sweden. third ed.
27. European Pharmacopeia Uniformity of Content Single-Dose Preparations 2013, Directorate for the quality of medicines and healthcare of the concil of Europe, Strasbourg, France. seventh ed.